Skye Bioscience flags Nasdaq noncompliance after stockholders’ equity falls to ($497,307)
Reuters2026/08/19 10:04- Nasdaq flagged Skye Bioscience for failing to meet the $2.5 million minimum stockholders’ equity requirement under Listing Rule 5550(b)(1).
- Stockholders’ equity was ($497,307) in its Form 10-Q for the quarter ended June 30, 2026.
- Shares continue trading on Nasdaq under “SKYE” with no immediate impact.
- Skye must submit a compliance plan by Oct. 2, 2026; Nasdaq could extend the cure period to Feb. 14, 2027.
- Failure to regain compliance could trigger delisting proceedings, with an appeal option that would keep the stock listed during review.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Dow Jones Top Energy Headlines at 7 AM ET: Oil Rises on Persistent Hormuz Uncertainty | Energy ...
US MBA Mortgage Survey Of Current Interest Rates
Alphabet (GOOGL.US) raises AUD 3.9 billions in its first Australian dollar bond issuance, adding to the global wave of intensive fundraising by tech companies.
According to a list of terms seen by foreign media, American tech giant Alphabet has successfully raised 5.5 billion AUD (approximately 3.89 billion USD) through its first Australian dollar bond issuance, adding another chapter to the recent wave of intensive financing by global tech companies.
Crypto prices
More
